Press Releases

National Brain Tumor Society Comments on Final Results From EF-14 Trial of Optune Device in Newly Diagnosed Glioblastoma Patients Today, the final analysis of data from the EF-14 trial was published in the Journal of the American Medical Association (JAMA). EF-14 was a pivotal, international phase 3 clinical trial that compared newly diagnosed glioblastoma patients using tumor-treating device, Optune, in combination with the chemotherapy temozolomide (Temodar) to those receiving temozolomide alone, following surgery and […] December 19, 2017

National Brain Tumor Society Presents The Policy Resolution Group (PRG) at Bracewell LLP with its Brain Tumor Champion Award National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, announced that is has presented The Policy Resolution Group (PRG) at Bracewell LLP, a leading law and government relations firm, with its Brain Tumor Champion Award. The award is in recognition for its contributions and service to […] December 18, 2017

National Brain Tumor Society Statement on the Full Approval of Avastin Last night, we learned that the U.S. Food & Drug Administration (FDA) has granted full approval for the use of the drug Avastin (bevacizumab) to treat adult recurrent glioblastoma patients. In 2009, Avastin was granted conditional approval in this setting under the FDA’s accelerated or conditional approval program. The FDA’s decision to move the drug from a conditional approval to […] December 6, 2017

National Brain Tumor Society 2017 Scientific Summit Showcases Research & Treatment Development Opportunities in Neuro-Oncology Field Top experts from across sectors of brain cancer research – government, industry, academia, medical, patients, and advocates – discuss how to address biggest unmet barriers to new treatments and a cure National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, recently hosted its annual Scientific Summit […] October 26, 2017

NBTS Statement: Rally Foundation for Childhood Cancer Research Makes an Investment in the Defeat Pediatric Brain Tumors Research Collaborative Rally Foundation for Childhood Cancer Research recently announced a grant for $50,000 to the National Brain Tumor Society, the largest nonprofit dedicated to the brain tumor community in the United States, to support the organization’s subsidiary, the Defeat Pediatric Brain Tumors Research Collaborative. National Brain Tumor Society Chief Executive Officer David F. Arons, JD, released the […] September 20, 2017